Introduction
The Shc proteins are a family of adaptors containing Nterminal PTB and C-terminal SH2 domains (Ravichandran, 2001 ), each of which bind phosphorylated tyrosine (pTyr) residues in the context of specific amino acid sequences. ShcA is the most widely expressed of four mammalian Shc proteins, and its primary role is in signalling from activated receptors at the cell surface. These include receptors for growth factors (Ravichandran et al, 1995; Ricketts et al, 1996; Ganju et al, 1998; Meakin et al, 1999; Hennige et al, 2000; Finlayson et al, 2003; Motegi et al, 2004) , antigens (Ravichandran et al, 1993; Pratt et al, 1999; Patrussi et al, 2005; Fukushima et al, 2006) , and cytokines (Dorsch et al, 1994; Bates et al, 1998; Hunt et al, 1999) , as well as integrins (Mainiero et al, 1995; Wary et al, 1996; Mauro et al, 1999; Cowan et al, 2000; Dans et al, 2001; Weyts et al, 2002) and GPCRs (Luttrell et al, 1997; Schafer et al, 2004; Natarajan and Berk, 2006) . Recruitment of ShcA to assorted membrane proteins results in its phosphorylation on three tyrosine residues (Y239/40 and Y313) in a central CH1 domain that subsequently activate the Ras/MAPK pathway through the recruitment of Grb2 and SOS (Salcini et al, 1994; van der Geer et al, 1996) . PTB domain interactions typically mediate ShcA association with surface receptors. Selectivity is achieved through recognition of linear motifs with the consensus sequence FXNPXpY (F being a hydrophobic residue and X representing any amino acid) (Uhlik et al, 2005) . A structure of the ShcA PTB domain complexed with a 12 residue phosphopeptide from the juxtamembrane of TrkA was solved by NMR spectroscopy (Zhou et al, 1995b) . PTB domains, now identified in over 50 human proteins, share a similar core fold consisting of a central b-sandwich capped on one end by a conserved C-terminal a-helix, and on the other by a variable length a-helix found between strands b1 and b2 (or b2 and b3). The canonical peptide-binding groove is located between the fifth b-strand and the C-terminal a-helix (a3 in Shc); however, PTB domains possess surprisingly flexible binding properties including a variable dependence on phosphorylation of the NPXY tyrosine (Uhlik et al, 2005) . Numerous PTB domains (i.e. Dab or Numb) bind irrespective of phosphorylation or preferentially recognize unphosphorylated ligands, but members of the Shc and IRS-1/Dok families bind with higher affinity to phosphorylated motifs and serve as adaptors in normal and oncogenic receptor tyrosine kinase (RTK) signalling.
Although stimulation of the Ras pathway is a major component of Shc function, there are reasons to believe that Shc is involved in diverse processes. Though ShcA is an evolutionarily conserved protein, there is an intriguing absence of Y239/40 and Y313 tyrosines in more ancient orthologs. None of the three Shc-like proteins in nematodes contain these sites, and Drosophila Shc (dShc) has Y239/40 but not Y313; it is only in the chordate lineage that these are fixed. As Y313 appears to be the more potent Ras/MAPK activator, the absence of this phosphorylation site could limit the ability of dShc to stimulate the Ras/ERK pathway (Lai et al, 1995; Velazquez et al, 2000) . These data imply a basic function for ShcA independent of its tyrosine phosphorylation, association with Grb2, or activation of MAPK. In support of this idea, ShcA has been reported to regulate c-Myc expression (Gotoh et al, 1997) , play a role in cell survival (Gotoh et al, 1996) , and control aspects of cytoskeletal architecture (Khoury et al, 2001) .
Mice lacking ShcA die at E11.5 with cardiovascular defects, including lack of cardiac trabeculation, deficiencies in angiogenesis, and maintenance between endothelial and mesenchymal cell contacts (Lai and Pawson, 2000) . Whole mount immunostaining also revealed a loss of MAPK activity using pERK antibodies. However, recent work has shown that a significant fraction of transgenic mice expressing ShcA proteins in which Y239/40 and Y313 have been replaced with phenylalanine (henceforth referred to as ShcA 3F ) are viable (Hardy et al, 2007) . Though ShcA 3F/3F mice that live to adulthood exhibit severe ataxia, this is a much milder phenotype than that observed for mice expressing ShcA lacking PTB domain function (E11.5 lethal, similar to ShcA À/À ).
These results support the notion that the central pTyr motifs in ShcA are dispensable for some of its biological activity, and hint that ShcA may have entirely independent signalling properties.
To search for unidentified pathways in the ShcA signalling network, we took a mass spectrometry-based approach to isolate new binding proteins. In this paper we show that ShcA interacts with the versatile scaffolding protein IQGAP1 (IQ-motif containing with homology to RasGAPs). This interaction is mediated through the ShcA PTB domain via a non-canonical binding mode, and we provide evidence that ShcA and IQGAP1 function downstream of activated receptors.
Results

Identification of novel ShcA-binding proteins
To begin exploring alternative pathways of ShcA signalling, we used a mass spectrometry-based approach to reveal unidentified binding partners. As bait, Flag-tagged wild-type p52 ShcA or ShcA 3F were stably expressed in Rat1 fibroblasts ( Figure 1A ) . The 3F protein carries Tyr-to-Phe mutations in the three CH1 domain residues that are targets for Grb2 (Y239/40 and Y313). We co-expressed in these cells an activated RTK ErbB2-YD, which carries a V664E mutation in the transmembrane region that increases homodimerization (Bargmann and Weinberg, 1988) , and has only the ShcA PTB domain-binding site in the C-terminal tail (as defined by Dankort et al, 1997) . This induced a transformed phenotype to these fibroblasts ( Figure 1B) . Proteins bound to ShcA after immunoprecipitation were separated by SDS-PAGE and stained with colloidal coomassie ( Figure 1C ). Cells expressing ErbB2-YD alone were used as a control. Proteins that associated specifically with both wild type and ShcA 3F were excised and identified by tandem mass spectrometry (LC-MS-MS). A protein of 197 kDa, equally visible in precipitations of both mutant and wild-type ShcA, was identified as IQGAP1. No IQGAP1 peptides were found from a corresponding region of the control lane. IQGAP1 is known to affect MEK/ERK activation (Roy et al, 2005) and has been linked to growth factor signalling and cytoskeletal rearrangements (Yamaoka-Tojo et al, 2004; Bensenor et al, 2007) . Thus, we sought to further confirm this interaction and determine whether it was significant to ShcA signalling.
Verification of an ShcA interaction with IQGAP1
To validate the mass spectrometry result, we tested whether ShcA and IQGAP1 could be co-purified from Rat1 fibroblasts. We used wild-type Rat1 cells grown in standard media (10% serum), cells starved overnight and stimulated with EGF, or cells stably expressing ErbB2-YD. As several IQGAP1 interactions are mediated by Ca 2 þ /calmodulin, we also grew cells in media either lacking or supplemented with Ca 2 þ ( Figure 1D ). After the immunoprecipitation of endogenous Shc, we observed co-precipitation of IQGAP1 from all conditions ( Figure 1D ). Subsequently, we tested the requirement for the CH1 domain residues Y239/40 and Y313 using HEK 293T cells co-transfected with HA-tagged IQGAP1 and Flagtagged wild type or 3F ShcA. IQGAP1 was co-precipitated with both proteins ( Figure 1E ). These data corroborate an interaction, provide evidence that the Shc CH1 tyrosines are not required for association with IQGAP1, and indicate that ErbB2 activity is not strictly required for formation of the complex.
Membrane recruitment of ShcA and IQGAP1
We next considered whether ShcA and IQGAP1 interact in cells. ShcA is generally cytoplasmic or ER localized, and is re-distributed upon receptor activation to the cell surface (Lotti et al, 1996) . IQGAP1 is found in a Ca 2 þ -regulated complex with calmodulin (Ho et al, 1999) , but in multiple cell types can accumulate at the leading edge of migrating cells (Mataraza et al, 2003 (Mataraza et al, , 2007 Watanabe et al, 2004; Yamaoka-Tojo et al, 2004) . We initially utilized the Rat1 cell lines expressing ErbB2-YD and EGFP/Flag-ShcA ( Figure 1A and B). The ErbB2-YD receptor is able to signal downstream through ShcA, but unlike wild-type ErbB2 has no direct Grb2-binding sites (Dankort et al, 1997 ). Wild-type cells showed pools of endogenous IQGAP1 localized generally in the cytoplasm, as well as to the cell cortex in cells nearing the edge of a monolayer (Figure 2A ). However, we observed a clear loss of cytoplasmic IQGAP1 and its substantial recruitment to membrane ruffles along the leading edges of cellular protrusions in those cells which express ErbB2-YD and EGFPShcA. Although we detected exogenously expressed EGFPShcA or EGFP-ShcA 3F in these regions, they also remained prominent throughout the cytoplasm. In contrast to IQGAP1, a control protein that is also cytoplasmic in unstimulated cells (GAPDH) was not significantly recruited to membrane ruffles ( Figure 2B ). As ErbB2-YD signals through ShcA, these data signified that receptor activation may promote a ShcA interaction with IQGAP1 that is not dependant on the phosphorylation of its CH1 tyrosines.
To address the dependence of IQGAP1 localization on exogenously expressed ShcA, wild-type Rat1 cells were immunostained for the endogenous proteins ( Figure 2C ). Both IQGAP1 and Shc were generally cytoplasmic in unstimulated cells, particularly localized in the perinuclear region (with IQGAP1 also in the cell cortex in cells nearing the edge of a monolayer). We then examined cells expressing ErbB2-YD, and once more found IQGAP1 in membrane regions, wherein it co-localized with a fraction of Shc. The Shc proteins remained prominent throughout the cytoplasm. Finally, we monitored the effect of EGF on IQGAP1 and Shc localization in wild-type fibroblasts. After 20 min of stimulation, Shc was clearly detected in EGFinduced endosomes (see also Supplementary Figure S1A ).
It is interesting to note that IQGAP1 was not observed in these punctate vesicles and remained in the cytoplasm as well as concentrated at membrane ruffles. This evidence suggested that IQGAP1 membrane recruitment by activated receptors does not require the overexpression of ShcA, and that IQGAP1 does not interact with ShcA after receptor internalization.
IQGAP1 has a role in regulating epithelial cell junctions that is distinct from its activity in fibroblasts (Kuroda et al, 1998) . We therefore chose to examine ShcA and IQGAP1 in 5637 bladder carcinoma cells, which show moderate but stable cell-cell contacts (Supplementary Figure S1B) . Although IQGAP1 showed a basolateral distribution in these cells (similar to E-cadherin or b-catenin), Shc was localized in the cytoplasm. Stimulation of these highly metastatic cells with EGF-induced rapid and extensive membrane ruffling around the edges of the monolayer. Immunostaining for IQGAP1 and ShcA revealed their presence in these lamellipodia, along with actin, after 5 min of EGF treatment ( Figure 3A ). Similar results were obtained in the A431 skin carcinoma cell line (Supplementary Figure S1C ), but not with MDCK cells in which EGF-induced membrane ruffling was notably diminished or even absent (Supplementary Figure  S2 ). Previous work has demonstrated similar dynamics upon EGF stimulation for fluorescently tagged Grb2 adaptor proteins (Sorkin et al, 2000) , and to some extent ShcA (Sato et al, 2000) . We consequently tested whether exogenously expressed, Venus-tagged IQGAP1 could be recruited to membranes upon EGF stimulation in 5637 cells. Indeed, although Grb2, ShcA, IQGAP1, and the Venus control are equally localized throughout the cytoplasm in unstimulated cells, only the Grb2, ShcA, and IQGAP1 proteins demonstrated clear membrane recruitment 5 min after the addition of EGF ( Figure 3B ). The Venus control remained cytoplasmic and displayed no or very little localization to the membrane. Moreover, we once more failed to observe IQGAP1 in the punctate endosomal vesicles that are evident in ShcA or Grb2 expressing cells following 20 min of EGF stimulation. This work corroborates our biochemical data, and establishes ShcA and IQGAP1 co-recruitment to membrane regions in both fibroblast and epithelial cell lines.
To further explore the role of ShcA in recruiting IQGAP1 to the cell cortex, we examined cells with reduced levels of ShcA protein for changes in IQGAP1 localization. Clonal lines of 5637 cells stably expressing shRNA against all three isoforms of ShcA were established, along with control lines expressing a scrambled shRNA sequence ( Figure 4A ). These cells were subjected to a time course of EGF stimulation, and control cells exhibited strong lamellipodia formation 5 min post-induction, in a manner analogous to wild-type cells. However, cells with reduced levels of ShcA showed greatly diminished levels of membrane ruffling, in most cases presenting no perceptible lamellipodia ( Figure 4B and Supplementary Figure S3A ). To determine whether IQGAP1 was still being recruited to the outer cortex in ShcA-knockdown cells, we immunostained these cell lines with antibodies against endogenous IQGAP1. Though control cells clearly retained the capacity to recruit IQGAP1 to membrane ruffles, there was no detectable change in IQGAP1 localization in ShcA-reduced cells upon stimulation with EGF ( Figure 4C ). Even treatment with significantly higher concentrations of EGF (100 ng/ml) failed to induce strong membrane ruffling in ShcA-knockdown cells (Supplementary Figure S3B /C). This lack of lamellipodia formation in ShcAdepleted cells likely correlates with a decrease in Rac1 activity. The loss of IQGAP1 has been highly associated with reduced migration in numerous cell types, and it is a powerful effector of Rac1 (Mataraza et al, 2003; Noritake et al, 2004; Watanabe et al, 2004) . These data support a role for ShcA in recruiting IQGAP1 to membrane proximal regions in growth factor-stimulated cells. Venus-tagged proteins, as well as Venus alone, were expressed in 5637 cells, where they are localized throughout the cytoplasm and nucleus (apart from ShcA, which is not detected in the nucleus; column 1). Cells were EGF stimulated for 5 min (column 2) or 20 min (column 3). Grb2, Shc, and IQGAP1 all showed early membrane localization, whereas the Venus control protein did not. Only Grb2 and ShcA were detected in EGF-containing endosomes at 20 min. Bar ¼ 10 mm.
Establishment of binding requirements for the
with the ShcA PTB or SH2 domain. To begin examining this, we first chose to study IQGAP1 phosphorylation and its relationship with ShcA. We have detected a basal IQGAP1 tyrosine phosphorylation using anti-pTyr antibodies ( Figure 5A ). To determine whether phosphorylation is further stimulated by RTKs, we monitored IQGAP1 pTyr levels in cells expressing ErbB2-NT (carrying the V664E activating mutation and all five C-terminal pTyr sites; as defined in Dankort et al (1997) ). Not only was IQGAP1 phosphorylation significantly increased by ErbB2, but overexpression of ShcA could further augment this ( Figure 5B ). Moreover, there was an enhanced capacity for hyperphosphorylated IQGAP1 to co-precipitate ShcA compared to IQGAP1 with only basal levels of phosphorylation. These data support a relationship between IQGAP1 pTyr levels and its interaction with ShcA, but do not yet clarify whether the PTB or SH2 domains might mediate a direct interaction.
To map the IQGAP1-binding site, we carried out a series of in vitro-binding experiments. GST-tagged ShcA PTB and SH2 domains were expressed and purified from Escherichia coli. Glutathione beads carrying the recombinant domains were incubated with cell lysates expressing HA-tagged IQGAP1, and co-precipitating proteins were identified by anti-HA immunoblot. Though both domains consistently pulled down IQGAP1, the PTB domain interaction was considerably more robust ( Figure 5C ). This experiment is complicated by the ability of IQGAP1 to oligomerize, as well as its affinity for actin and microtubules (Bashour et al, 1997; Fukata et al, 2002; Ren et al, 2005) . We therefore sought to narrow the region of IQGAP1 targeted by ShcA using a set of truncation mutants ( Figure 5D ) and Far Western analysis.
IQGAP1 fragments expressed and purified as HA-tagged proteins were separated by SDS-PAGE and transferred to a nitrocellulose membrane. The resulting membranes were incubated with GST-tagged PTB or SH2 domain, and direct interactions detected by anti-GST immunoblot ( Figure 5E ). Even though we observed no binding between IQGAP1 and the SH2 domain of ShcA (or GST alone), the PTB domain bound every fragment except DN. This suggested a direct interaction between the ShcA PTB domain and the N-terminal half of IQGAP1, in a region upstream of the WW domain.
In order to further categorize the binding site, we expressed and purified a series of GST-tagged fragments covering the entire N-terminal region (IQGAP1 residues 1-641). These were mixed with Ni-NTA beads carrying Histagged PTB domain (or SH2 domain as a control), and bound proteins were identified by anti-GST immunoblot ( Figure 6A ). One fragment, spanning residues 401-533 of IQGAP1 (henceforth referred to as IQGAP1 401À533 ), was consistently precipitated by the PTB domain, whereas none interacted with SH2 domain. Unexpectedly, the interaction occurred directly after purification from E. coli, or with preincubation in EGF-activated cell lysates (not shown). This indicated that ShcA associates with IQGAP1 residues 401-533 even in the absence of tyrosine phosphorylation. As this is a non-canonical interaction for the ShcA PTB domain, we sought to further describe the binding mode.
NMR characterization of the PTB domain interaction with IQGAP1
401À533
ShcA is considered to have an archetypal pTyr-dependent PTB domain, but many PTB domains recognize motifs with a diverse set of properties (Forman-Kay and Pawson, 1999; Margolis et al, 1999) . To explore how the ShcA domain associates with IQGAP1 401À533 , we utilized NMR to obtain residue-specific information on this protein-protein interaction. Multi-angle light scattering indicated that the 15 kDa IQGAP1 fragment was monomeric in solution, and CD data that it was a-helical in nature (Supplementary Figure S4) . 1 H/ 15 N heteronuclear single quantum coherence (HSQC) spectra of isotopically labelled IQGAP1 401À533 also showed the protein to be well-folded. To begin examining its interaction with the PTB domain, we obtained nearly complete backbone resonance assignments for the free PTB domain (residues 17-207) and IQGAP1 401À533 fragment (86 and 91% respectively) using standard triple resonance experiments (HNCA, HNCACB, and CBCACONH). Upon titration of IQGAP1 401À533 into 15 N-labelled PTB domain we observed significant peak broadening, indicative of an intermediate exchange regime. At low ratios (1 PTB domain:2 IQGAP 401À533 ) coalescence appeared specific for particular residues ( Figure 6B) . Conversely, the titration of unlabelled PTB domain into 15 N-labeled IQGAP1 401À533 yielded specific but more extensive broadening ( Figure 6C ). These data helped confirm a direct interaction that is distinguished by intermediate exchange on the NMR time-scale, usually indicative of micromolar affinities.
The coalescence observed by this exchange regime is unfortunately detrimental to detailed structural determination. However, data obtained from peak-intensity changes were sufficient to identify a binding interface on the surface of the PTB domain. First, peak intensities derived from HSQC spectra of 300 mM free PTB domain, and PTB domain in the presence of 600 mM IQGAP1 401À533 , were calculated. The ratio (unbound/bound) of all assigned and non-overlapping backbone resonances were plotted ( Figure 7A ). It was clear that seven peaks exhibited extremely high levels of broadening compared with others (K139, I142, S149, G156, V167, K169, and V172). When mapped on the previously solved structure of the ShcA PTB domain in complex with an NPXpY peptide from TrkA (PDB:1SHC; (Zhou et al, 1995b) ), these residues cluster to a surface region adjacent to the classic peptidebinding groove ( Figure 7B ). This signified a potentially atypical binding mode for IQGAP1, and we next considered which residues in the IQGAP1 fragment are involved in the interaction.
We carried out a similar peak-intensity analysis on IQGAP1 401À533 after first establishing an order of 21 structure elements using chemical shift indices (CSI; Figure 7C ). This revealed a topology of five a-helices, but suggested helices 1 and 2 may be less well-defined than helices 3-5. Normalized peak intensities from HSQC spectra of 200 mM free 
IQGAP1
401À533 , and IQGAP1 401À533 in the presence of 400 mM PTB domain, were calculated and plotted ( Figure 7D ). We observed a more universal broadening in the IQGAP1 ligand, encompassing most of C-terminal a-helices 3, 4, and 5 ( Figure 7E ). This provides evidence that the ShcA PTB domain may require more than a short peptide motif to recognize IQGAP1, again suggesting a binding mode that may differ from more conventional NPXpY ligands.
ShcA PTB domain interactions with non-pTyr-based ligands
Nearly all ShcA PTB domain ligands contain the NPXpY motif, yet one previously identified binding partner is pTyrindependent. This consists of an NPLH sequence in the PTP-PEST phosphatase (Charest et al, 1996) , an interaction likely analogous to NPXpY binding because of conservation of several key residues in the motif (FXNPXX). We therefore examined binding to a PTP-PEST-derived peptide by NMR (PLSFTNPLHSDDWH; Supplementary Figure S5 ). This peptide bound with a K d of 6.9 mM as measured by ITC, and associated in the typical b5-a3 groove as determined by comparison with TrkA binding (Farooq et al, 2003) . Using a molar excess of peptide, 86% of backbone amide resonances were assigned for the NPLH-bound PTB domain ( Figure 8A ). We next chose to establish if PTB domain binding to the two ligands (NPLH and IQGAP1 401À533 ) could happen independently, or was mutually exclusive. To address this, we tested whether an interaction with the NPLH peptide could protect PTB domain amide resonances from exchange broadening induced by IQGAP1 401À533 . Isotopically labelled PTB domain was mixed with NPLH peptide at a 1:5 molar ratio to present two peaks (bound and unbound) of relatively equal intensity. Upon addition of IQGAP1 401À533 we observed significant coalescence, as before ( Figure 8B ), but peaks originating from the NPLH-bound PTB domain were not as severely broadened in the residues most involved with binding to IQGAP1 401À533 (seven obtained from Figure 7A ). We measured broadening ratios as a function of peak intensity (unbound/bound) after normalization to maximum signal strength. Figure 8C shows these ratios for free and NPLHbound PTB domain resonances derived from both highly and more minimally broadened peaks. Data from 12 resonances not substantially affected by IQGAP1 401À533 (five randomly selected are shown) displayed equal broadening for unbound PTB domain (1.24 ± 0.2) versus NPLH-bound (1.14 ± 0.3), whereas severely broadened peaks (5/7 measurable) showed significantly higher levels for unbound (2.02±0.3) compared with NPLH-bound (1.42 ± 0.3). This suggests that binding to the PTP-PEST peptide conveys a level of protection from the coalescence induced by IQGAP1 401À533 , and that PTB domains occupied in the a3-b5 groove are less likely to interact with IQGAP1.
Discussion
ShcA and IQGAP1 recruitment to surface receptors
We have investigated the possibility that ShcA can signal downstream of activated receptors through pathways other than Grb2-SOS. The absence of Grb2-binding motifs in numerous invertebrate Shc orthologs, and the survival of G S T A lo n e G S T -I Q G A P 1 ( 1 -2 1 1 ) G S T -I Q G A P 1 ( 1 5 8 -2 6 7 ) G S T -I Q G A P 1 ( 2 6 8 -4 0 0 ) G S T -I Q G A P 1 ( 4 0 1 -5 3 3 ) G S T -I Q G A P 1 ( 5 3 4 -6 4 1 ) . Two peaks with ordinarily high levels of broadening in the absence of NPLH peptide are shown, as well as two exhibiting lower levels. Resonances derived from unbound PTB domain are marked with 'U', and those from peptide-bound with 'B'. (C) Quantitation of peak intensity changes from PTB domain-NPLH complex in the presence or absence of IQGAP1 401À533 . Intensities were normalized to maximum signal strength, and ratio (unbound/bound) plotted for 5/7 peaks that display extensive broadening, and for peaks broadened to a lesser extent (random five selected). Unbound PTB domain data is dark blue or red, and NPLH-bound PTB domain in light blue or red. Average ratio for the typically broadened peaks on the unbound domain (2.02 ± 0.3) is significantly greater than on NPLH-bound (1.42 ± 0.3). Data from 12 other peaks, including the 5 shown, indicate relatively equal broadening (1.24 ± 0.2 unbound versus 1.14 ± 0.3 when NPLH-bound).
ShcA
3F/3F mice indicate that alternative signalling pathways are an important component of ShcA function. Both wild type and ShcA 3F co-precipitated IQGAP1, a scaffolding protein known to effect cytoskeletal rearrangement (Kuroda et al, 1996) , the MAPK pathway (Roy et al, 2005) , Ca 2 þ /calmodulin signalling (Psatha et al, 2006) , and cadherin/cateninmediated adhesion (Kuroda et al, 1998 (Kuroda et al, , 1999 . Recent evidence linking IQGAP1 to EGF and PDGF (Blagoev et al, 2004; Kratchmarova et al, 2005) , VEGF (Yamaoka-Tojo et al, 2004; Meyer et al, 2008) , and FGF (Bensenor et al, 2007) signalling is consistent with a ShcA interaction, as this adaptor could recruit IQGAP1 to sites where receptors are engaging downstream proteins. Thus, we explored the possibility of a ShcA-IQGAP1 complex, which could have a role in effecting cytoskeletal changes downstream of activated receptors and represents the first steps towards the elucidation of Grb2-independent ShcA signalling.
Our data demonstrate that IQGAP1 is recruited to the cell surface along with ShcA. We detect both ShcA and IQGAP1 at membrane ruffles in fibroblasts expressing constitutively active ErbB2-YD, and both proteins are redistributed to lamellipodia around the edges of 5637 or A431 monolayers stimulated with EGF. This compares well with previous data linking IQGAP1 to insulin-induced ruffles in KB cells (Kuroda et al, 1996) , VEGF-induced ruffles in endothelial cells (Yamaoka-Tojo et al, 2004) , and FGF-induced ruffles in MDBK cells (Bensenor et al, 2007) . We also demonstrate that cells with reduced levels of ShcA are deficient in lamellipodia formation after EGF stimulation, and that IQGAP1 tyrosine phosphorylation is induced by ErbB2 and further augmented by the overexpression of ShcA. Phosphorylation of IQGAP1 seems to be a widespread consequence of growth factor stimulation (Blagoev et al, 2004; Yamaoka-Tojo et al, 2004; Kratchmarova et al, 2005; Bensenor et al, 2007) , yet the purpose for this remains unknown. As previous work implicated IQGAP1 in activation of Ras/MAPK signalling from the EGFR (Bourguignon et al, 2005; Sacks, 2006) , we initially considered that its interaction with ShcA could restore some of the activity lost as a result of the 3F/Grb2-binding mutation. However, we have been unable to demonstrate this property of IQGAP1 (Supplementary Figure S6 ; Roy et al, 2004 Roy et al, , 2005 , and its ability to mediate Ras/MAPK activation through ShcA is still unclear. Instead, we believe the functional significance of ShcA-IQGAP1 redistribution to activated receptors involves cytoskeletal rearrangements mediated by IQGAP1 and Rho family GTPases.
ShcA has previously been implicated in a variety of cytoskeletal-mediated events, specifically cell migration and spreading. Cos7 cells in which ShcA is overexpressed have decreased numbers of actin stress fibres and a motile phenotype (Collins et al, 1999) . ShcA has also been shown to rapidly associate with the actin cytoskeleton upon stimulation with NGF (Thomas et al, 1995) , and is thought to influence activation of the Rac1 GEF, Vav1 (Groysman et al, 2002; Patrussi et al, 2007) . ShcA À/À embryos display cell-cell adhesion defects in the endothelium at E11.5, and MEFs derived from these mice display a rounded phenotype with abnormal focal complexes and actin stress fibres (Lai and Pawson, 2000) . We have preliminary evidence that these MEFs also show a reduction in IQGAP1 recruitment to the cell periphery upon EGF stimulation (M Smith, unpublished data). Most notably, knockdown of ShcA has been suggested to inhibit HRG-dependent migration and lamellipodia formation in ErbB2-YD expressing cells, implying an analogous mechanism to that observed in our EGF-based experiments in 5637 cells (Marone et al, 2004) . Finally, ShcA has previously been observed in membrane ruffles generated by EGFR/ ErbB2 chimeras (Lotti et al, 1996) . In fact, study of cellular transformation induced by ErbB2, which is amplified in 20-30% of human mammary carcinomas, provides intriguing evidence of Grb2-independent ShcA signalling. Four pTyr sites in the cytoplasmic tail of ErbB2 have potent transforming potential in fibroblasts, two of which recruit Grb2 either directly (YB-Y1144) or through ShcA (YD-Y1226/7) (Dankort et al, 1997) . However, activated ErbB2 receptors having only the YB or YD sites have distinct abilities to promote epithelial-mesenchymal transition (EMT). Although the YD-ShcA site promotes breakdown of E-cadherin junctions and dispersal of epithelial colonies, the YB-Grb2 site does not (Khoury et al, 2001) . It is possible that a lack of IQGAP1 recruitment by Grb2 alone is at least partially responsible for the observed decrease in motility and preservation of E-cadherin contacts in ErbB2-YB expressing cells. Indeed, IQGAP1 has been implicated in the metastasis of many cancers (Clark et al, 2000; Johnson et al, 2009) , and has been shown to effect cytoskeletal changes and cadherin-mediated adhesion downstream of growth factor receptors. IQGAP1 association with VEGFR-2 is the best-characterized link between IQGAP1 and growth factor signalling to date. In a mechanism seemingly distinct from ShcA-mediated IQGAP1 recruitment downstream of ErbB-family receptors, IQGAP1 associates with VEGFR-2 either directly (YamaokaTojo et al, 2004) or through a bridging connection mediated by c-Src (Meyer et al, 2008) . VEGF stimulation results in IQGAP1 phosphorylation and re-distribution to membrane ruffles, which involves activation of Rac1 and breakdown of VE-cadherin-mediated contacts. This corroborates the idea that ShcA-IQGAP1 recruitment to ErbB-family receptors could influence cell shape and motility through Rac1. Rac activation stimulated by growth factor receptors is known to be crucial for lamellipodia formation, cell spreading, and migration, yet the intracellular pathways connecting cellsurface receptors to Rac are still poorly understood. Although activation is achieved by recruiting GEFs such as SOS and Vav2 (Pandey et al, 2000; Kurokawa et al, 2004; Sini et al, 2004) , effectors would be essential components for altering cell shape and movement. As IQGAP1 functions to stabilize Rac1 and Cdc42 in their GTP-bound states, and data have shown that it can directly bind and polymerize actin (Bashour et al, 1997; Bensenor et al, 2007; Le Clainche et al, 2007) , IQGAP1 should be considered an effector for these GTPases (Zhang et al, 1998; Kurella et al, 2009) . Intriguingly, the presence of IQGAP1 in cells has proven to be an absolute requirement for the proper development of filopodia and lamellipodia (Fukata et al, 2002; Le Clainche et al, 2007) . Indeed, the loss of IQGAP1 signals a decrease in motility for numerous cell types (Bensenor et al, 2007; Dong et al, 2008; Jadeski et al, 2008) , and is the likely explanation for the absence of EGF-induced lamellipodia in 5637 cells with reduced levels of ShcA. We can therefore speculate that ShcA-mediated IQGAP1 signalling from growth factor-stimulated receptors leads to Rho-family GTPase activity, directing lamellipodia formation and motility. Figure S7A/B) . We have also been unable to derive any short peptides from this region that are recognized by ShcA (Supplementary Figure S7C/D) . Furthermore, an intermediate exchange regime is not typical of ligands binding in the a3-b5 groove (most exhibit slow exchange characteristics (Zhou et al, 1995a; Li et al, 1998 Li et al, , 2008 Yan et al, 2002; Stolt et al, 2004) ), and at the very least this is indicative of uncharacteristic kinetic properties for this interaction when compared to NPXpY-type ligands. Finally, IQGAP1-induced broadening was specific to seven PTB domain resonances that cluster to a region outside of the usual a3-b5 binding pocket. High-resolution structural data are required to determine whether there is an overlap between these sites, but the seven PTB domain residues are completely conserved in four mammalian Shc homologues and in more ancient orthologs. IQGAP1 residues 401-533 are also well conserved (over 90% identity in mammalian IQGAP1s). This suggests preservation of the ShcA-IQGAP1 complex and hints that other Shc proteins may be similarly involved with members of the IQGAP family.
Classical ligands of the NPXpY variety bind the ShcA PTB domain with high affinity, having dissociation constants ranging from 53 nM (TrkA pY490) to 5.3 mM (EGFR pY1086) (Zhou et al, 1995a) . We were unable to resolve an accurate K d for IQGAP1
401À533 using ITC, because of highly unfavourable heats of dilution, yet binding appears to be in the high mM range and weaker than NPXpY peptides. One intriguing possibility is that this affinity could be augmented by oligomerization of IQGAP1, whereby multiple sites could impart avidity. Data have shown that IQGAP1 exists as a combination of monomers, dimers, and larger oligomers, and that this is dependent on residues in the N-terminal region (763-863) directly adjacent to our identified PTB domain-binding site (Ren et al, 2005) . Future assays employing larger fragments of the IQGAP1 protein should clarify this.
An NPLH sequence in PTP-PEST, thought to mediate negative regulation of lymphocyte activation (Davidson and Veillette, 2001) , was the only previously reported pTyr-independent target for the ShcA PTB domain. The conservation of Asn and Pro in the NPLH sequence suggested binding in the a3-b5 pocket, and comparison of our NMR chemical shift data with published results on TrkA (NPXpY) binding (Farooq et al, 2003) confirmed this (Supplementary Figure  S5C) . Competition between this peptide and IQGAP1 demonstrated a mutually exclusive relationship. Owing to the moderate affinity of the NPLH peptide (6.9 mM), the outcome would likely be more pronounced if a high-affinity NPXpY ligand were utilized. In fact, one of the seven PTB domain residues involved in the IQGAP1 interaction, Lys169, has a major role in coordinating pTyr recognition (Zhou et al, 1995b) . Previous data have also shown that the ShcA PTB domain operates by an induced-fit mechanism (Farooq et al, 2003) . When unbound, residues constituting the ligand-binding pocket in the NPXpY-bound form are structurally disordered, and are reorganized in the presence of peptide. This supports the idea that PTB domains engaged in the a3-b5 groove may no longer recognize IQGAP1.
Using the data described here, we propose a model for ShcA recruitment of IQGAP1 to activated receptors. In resting cells, the PTB domain of ShcA could mediate an interaction with IQGAP1 in the cytoplasm. We speculate this complex may be dependant upon oligomerization of IQGAP1, or its further regulation by binding partners such as calmodulin. Upon stimulation, ShcA would be recruited to membrane proximal sites, wherein activated receptors present pTyr residues in the context of NPXpY motifs. Owing to a higher PTB domain affinity for these sites, and its inability to associate with the two ligands simultaneously, IQGAP1 would dissociate and begin effecting cytoskeleton rearrangements and breakdown of cell contacts. ShcA would now activate Ras/MAPK through Grb2-SOS, and these signalling complexes can be observed in endosomal compartments where we do not detect IQGAP1.
We have demonstrated alternative modes of ShcA signalling, in which ShcA engages a transient interaction with IQGAP1 and promotes receptor-dependant signalling at lamellipodia. More work is now required to completely characterize the interplay between these proteins, and the functions of this complex in response to various extracellular stimuli.
Materials and methods
Plasmid constructs and antibodies, immunofluorescence, immunoprecipitation, circular dichroism and light scattering procedures are described in Supplementary data.
Cell culture HEK 293T, Rat1, Madin-Darby canine kidney (MDCK), A431 and 5637 cells were maintained in Dulbecco's modified Eagle's medium containing 10% heat-inactivated fetal calf serum and antibiotics. For exogenous expression, cells were transiently transfected with PEI (Boussif et al, 1995) , lipofectamine 2000, or lipofectamine LTX (Invitrogen). Selection was done in 1-2.5 mg/ml puromycin (Sigma). EGF (PeproTech) was added after culturing overnight in the absence of serum at indicated times and concentrations. Pervanadate stimulation was for 30 min at 371C.
Purification of recombinant proteins
Glutathione S-transferase or His-tagged proteins were expressed in E. coli BL21 cells grown in LB media by induction with isopropylb-D-thiogalactopyranoside (IPTG) at 151C overnight. Cells were lysed and sonicated in 20 mM Tris (pH 7.5), 150 mM NaCl, 10% glycerol, 0.4% NP-40, protease inhibitors (Roche), 1 mM phenylmethylsulfonyl fluoride (PMSF), 10 ng/ml DNase, and either 1 mM dithiothreitol or 10 mM b-mercaptoethanol. Lysate was cleared by centrifugation and incubated with glutathione (Amersham Pharmacia Biotech) or Ni-NTA (Qiagen) resin at 41C for 2 h. Bound proteins were eluted using 40 mM glutathione (Sigma), 250 mM imidazole (Bioshop), or thrombin cleavage (Calbiochem). Concentrated proteins were purified to homogeneity by size exclusion chromatography using either an S75 or S200 26/60 column (GE Healthcare).
Identification of interacting proteins by mass spectrometry
Rat1 cells were lysed in TX100 buffer (20 mM Tris (pH 7.5), 137 mM NaCl, 10% glycerol, 1% Triton X-100, 1 mM sodium vanadate, 1 mM PMSF, and protease inhibitors) and cleared by ultracentrifugation. Lysate was passed through a 0.45 mm filter (Pall Corporation) and pre-cleared with mouse agarose (Sigma) at 41C for 30 min. Supernatant was incubated with M2 Flag-agarose (Sigma) for 2 h at 41C. Beads were washed three times with TX100 buffer before elution with 1 mg/ml Flag peptide (20 min at RT). After separation by SDS-PAGE, proteins were visualized with colloidal coomassie (GelCode Blue Stain Reagent; Pierce). Bands were excised and reduced, alkylated, and digested with trypsin using a ProGEST Tryptic Digestion Robot (Genomic Solutions). Peptides were analyzed by LC-MS (HP 1100 HPLC System (Agilent) and LTQ Mass Spectrometer (ThermoElectron)). Resultant MS-MS spectra were searched using the MASCOT programme against the NCBI nonredundant DataBase.
Isothermal titration calorimetry (ITC)
Calorimetry experiments were performed using a Microcal VP-ITC instrument. Stock solutions were diluted into filtered and degassed 20 mM Tris (pH 7.5), 100 mM NaCl, and 1 mM DTT. Experiments were carried out at 201C. Heats of dilution were determined from control experiments in which peptide was titrated into buffer alone. Data were fitted using the software Origin 7 (Microcal).
NMR Spectroscopy
All NMR data were recorded at 25-301C on an 800 MHz Bruker AVANCE II spectrometer or 600 MHz Bruker AVANCE III spectrometer equipped with TCI CryoProbes. Two-dimensional 1 H/ 15 N HSQC (Bodenhausen and Ruben, 1980 ) spectra and triple resonance HNCACB (Wang et al, 1994) , CBCACONH (Grzesiek and Bax, 1993) , and HNCA (Ikura et al, 1990 ) spectra were collected for the backbone chemical shift assignments. All NMR samples were prepared in buffer containing 20 mM Tris (pH 7.5), 100 mM NaCl, 1 mM DTT, and 10% D 2 O. Peptide for titrations of sequence 'PLSFTNPLHSDDWH', derived from murine PTP-PEST (ID: 19248), was produced by Sigma. The spectra were processed with NMRPipe (Delaglio et al, 1995) and resonance assignments made with NMRView (Johnson, 2004 
Supplementary data
Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).
